Trial Profile
A phase II study on the efficacy and safety of topotecan in the treatment of patients with brain metastases.
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 14 Jun 2011
Price :
$35
*
At a glance
- Drugs Topotecan (Primary)
- Indications Brain metastases
- Focus Therapeutic Use
- 14 Jun 2011 New trial record